Jounce Therapeutics Initiates Phase 2 EMERGE Study of Vopratelimab in Combination with Ipilimumab in Patients with Non-Small Cell Lung Cancer or Urothelial Cancer

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement